Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma
(Q40953356)
scientific article published on February 1999
scientific article published on February 1999
Language:
Current Data About
Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||||||||||
| (P304) |
254-260
|
||||||||||||||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||||||||||||||
| (P433) |
2
|
||||||||||||||||||||||||||||||||
| (P478) |
48
|
||||||||||||||||||||||||||||||||
| (P577) |
Monday, February 1, 1999
|
||||||||||||||||||||||||||||||||
| (P1433) |
(Q895262)
|
||||||||||||||||||||||||||||||||
| (P1476) |
"Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma" (language: en)
|
||||||||||||||||||||||||||||||||
| (P2093) |
Wang M
Wise SC
Leff T
Su TZ
|